ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS

被引:0
|
作者
Rovida, E. [1 ]
Navari, N. [1 ]
Cannito, S. [2 ]
Dello Sbarba, P. [1 ]
Parola, M. [2 ]
Marra, F. [1 ]
机构
[1] Univ Florence, Florence, Italy
[2] Univ Turin, Turin, Italy
关键词
D O I
10.1016/S0168-8278(10)60893-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S347 / S347
页数:1
相关论文
共 50 条
  • [31] Risk factors for developing new nodules of hepatocellular carcinoma (HCC) in the liver apart from the primary subsegment after complete ablation by microwave or radiofrequency.
    Izumi, N
    Noguchi, O
    Asahina, Y
    Uchihara, M
    Hamano, K
    Kanazawa, N
    Itakura, J
    Kawazoe, S
    Miyake, S
    Sakai, T
    GASTROENTEROLOGY, 2000, 118 (04) : A913 - A913
  • [32] Incidence rates and risk factors associated with hepatocellular carcinoma (HCC) in patients with advanced liver disease due to hepatitis C: Results of the halt-C trial
    Lok, A. S.
    Seeff, L. B.
    Morgan, T. R.
    DiBisceglie, A. M.
    Sterling, R. K.
    Curto, T. M.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S45 - S45
  • [33] A Novel Approach for Preventing HCC Recurrence after LT: Adoptive Immunotherapy Using Donor Liver Natural Killer Cells To Prevent Hepatocellular Carcinoma Recurrence after Liver Transplantation
    Hotta, Ryuichi
    Ohira, Masahiro
    Tzakis, Andreas G.
    Vianna, Rodrigo
    Ohdan, Hideki
    Nishida, Seigo
    TRANSPLANTATION, 2015, 99 : 111 - 111
  • [34] The transmembrane protein tetraspanin 5 controls the effects of loss of the tumor suppressor deleted in liver cancer 1 (DLC1) on hepatocellular carcinoma (HCC) growth
    Schreyer, L.
    Mittermeier, C.
    Martin, D. E.
    Singer, S.
    Liebl, B.
    Gudermann, T.
    Aigner, A.
    Muehlich, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (SUPPL 1) : S14 - S14
  • [35] Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors
    Fraum, Tyler J.
    Cannella, Roberto
    Ludwig, Daniel R.
    Tsai, Richard
    Naeem, Muhammad
    LeBlanc, Maverick
    Salter, Amber
    Tsung, Allan
    Shetty, Anup S.
    Borhani, Amir A.
    Furlan, Alessandro
    Fowler, Kathryn J.
    EUROPEAN RADIOLOGY, 2020, 30 (02) : 996 - 1007
  • [36] Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors
    Tyler J. Fraum
    Roberto Cannella
    Daniel R. Ludwig
    Richard Tsai
    Muhammad Naeem
    Maverick LeBlanc
    Amber Salter
    Allan Tsung
    Anup S. Shetty
    Amir A. Borhani
    Alessandro Furlan
    Kathryn J. Fowler
    European Radiology, 2020, 30 : 996 - 1007
  • [37] Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue—influence of a modulated host stroma on the prognosis of HCC
    Frank Simon
    Maximilian Bockhorn
    Christian Praha
    Hideo A. Baba
    Christoph E. Broelsch
    Andrea Frilling
    Frank Weber
    Langenbeck's Archives of Surgery, 2010, 395 : 395 - 405
  • [38] OUTCOMES OF PREOPERATIVE TRANSARTERIAL CHEMOEMBOLIZATION (TACE) COMPARED TO UPFRONT LIVER RESECTION FOR LARGE (≥5CM) HEPATOCELLULAR CARCINOMA (HCC): A SYSTEMATIC REVIEW AND META-ANALYSIS
    Cheo, Feng-Yi
    Chan, Kai-Siang
    Tay, Wei-Xuan
    Shelat, Vishal
    GUT, 2022, 71 : A94 - A94
  • [39] Circulating tumor cells (CTC) in metastatic hepatocellular carcinoma (HCC): Comparison to control patients with nonmalignant liver diseases (NMLD) and exploratory characterization by next generation sequencing (NGS)
    Kelley, Robin Katie
    Magbanua, Mark Jesus Mendoza
    Butler, Timothy M.
    Sidiropoulos, Nikoletta
    Hwang, Jimmy
    Evason, Kimberley
    Hameed, Bilal
    Wayne, Elizabeth M.
    Yao, Francis Y.
    Siah, Iche
    Park, John W.
    Venook, Alan Paul
    Collisson, Eric Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [40] Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue-influence of a modulated host stroma on the prognosis of HCC
    Simon, Frank
    Bockhorn, Maximilian
    Praha, Christian
    Baba, Hideo A.
    Broelsch, Christoph E.
    Frilling, Andrea
    Weber, Frank
    LANGENBECKS ARCHIVES OF SURGERY, 2010, 395 (04) : 395 - 405